Our data from healthy controls and patients with DLBCL clearly show that CD14+HLA-DRlo/neg monocytes are distinct from immature LIN-CD33+HLA-DR- MDSCs. The gene discussed is CD33; the disease is diffuse large B-cell lymphoma.